Celebrating 15 years
of driving innovation
for Life Sciences in Europe

About EUCOPE

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) is Europe’s trade body that gives a bigger voice to small and mid-sized innovative companies working in the field of biopharmaceuticals and medical technologies. Through its members, EUCOPE represents 2600+ biopharmaceutical companies that are researching, designing, developing, supplying, manufacturing, and deploying the next generation of pharmaceutical innovation and therapeutic solutions around the continent.

Based in Brussels, Belgium, EUCOPE’s commitment is to lead and engage in partnerships spanning the entire medicine lifecycle to find actionable solutions that benefit our members, the patients they serve, and healthcare systems overall. As a trade association, we advocate for sound public policy that supports innovation, while fostering a community built on a shared purpose: improving and saving the lives of European patients through ground-breaking therapies and medical technology. We provide a platform for discussion on major healthcare topics and developments, provide ad hoc expertise and updates on national market access and HTA issues and ensure that our members’ voices are heard first in the early stages of policy-making and legislative procedures.

Read more…

Upcoming Events

16
May

16. May 2024 to 16. September 2024 — Register here

European Healthcare & Life Sciences Investor Symposium

The European Healthcare & Life Sciences Investor Symposium is a series of events held in Frankfurt, Paris and London during Spring and Summer 2024, organised by Latham & Watkins, together with the European Healthcare Investor Association and PwC UK. This event is a vital opportunity… read more

3
Jun

3. June 2024 — Register here

EUCOPE’s Life Science Lectures – Episode Five

The new EU HTA procedure: How can JCAs support access to OMPs for people living with rare diseases Episode 5 – 3 June 2024 (16:00 – 17:00 CET) The new Regulation (EU) 2021/2282 on Health Technology Assessment (HTA) will apply from 12 January 2025, to… read more

23
Oct

23. October 2024 to 25. October 2024 — Register here

World Orphan Drug Congress Europe 2024

The World Orphan Drug Congress is the largest and most established orphan drugs & rare diseases meeting of its kind across the globe.

5
Mar

5. March 2025 to 6. March 2025 — Register here

World EPA Congress 2025

The World Evidence, Pricing and Access Congress is Europe’s largest congress in market access, pricing and evidence featuring 300 speakers, multiple streams and over 1200 attendees from pharma, biotech and Payers/HTA’s. Join in Amsterdam for 2025! See here the agenda and speakers.

News & Updates

EUCOPE signs EURORDIS Open Letter #ActRare2024 at ECRD 2024

On 16 May 2024, EUCOPE signed EURORDIS Open Letter #ActRare2024, during the Closing Plenary session of the 12th European Conference on Rare Diseases and Orphan Products (ECRD), organised in Brussels on 15-16 May 2024. The Open Letter is a result of, and informed by, the… read more

Sounds of Science Podcast #18 on the Revision of the General Pharmaceutical Legislation

EUCOPE’s Sounds of Science Podcast – Episode 18 The Revision of the General Pharmaceutical Legislation: European Parliament Reports In this episode of Sounds of Science, we explore the ongoing Revision of the General Pharmaceutical Legislation (GPL). On 10 April,  the European Parliament adopted their reports… read more

EUCOPE signs the Joint Industry Statement on the European Commission’s Initiative “Boosting Biotechnology and Biomanufacturing in the EU”

On 25 April 2024, EUCOPE signed a Joint Statement on the European Commission’s Initiative “Boosting Biotechnology and Biomanufacturing in the EU”, together with key industry associations and organisations representing biotechnology across sectors. While focusing on the entire biotech sector, the Communication recognises the important role… read more

EUCOPE appointed to the new Critical Medicines Alliance

On 24 April 2024, EUCOPE was officially announced as a member of the Critical Medicines Alliance (“Alliance”). The Alliance is a consultative mechanism which brings together relevant stakeholders to identify priorities for action and propose solutions to better prevent and combat shortages of medicines, and to… read more

European Parliament formally adopts the European Health Data Space (EHDS) Regulation

Today, 24 April 2024, the European Parliament adopted the provisional agreement on the European Health Data Space (EHDS) Regulation. The compromise text was already endorsed by COREPER on 22 March, but still requires formal adoption by the Employment, Social Policy, Health and Consumer Affairs Council… read more

Job Opening: Join Our Team as a Dynamic Communications Manager

Are you passionate about shaping narratives and fostering connections? Do you thrive in dynamic environments where your creativity and strategic thinking can make a real impact? If so, we’re looking for someone just like you to join our team as a Communications Manager! About Us… read more

European Parliament adopts reports on the Revision of the EU General Pharmaceutical Legislation

On 10 April 2024, the European Parliament adopted the two reports on the Revision of the EU General Pharmaceutical Legislation, namely the Directive on medicinal products for human use and the Regulation on authorisation and supervision of medicinal products for human use and governing rules… read more

Life science industry concerns over the workability of EU HTA: Europe cannot miss out on the opportunity to speed up access to innovative medicines for European patients

In April 2024, the Alliance for Regenerative Medicines (ARM), the European Federation of Pharmaceutical Industries and Associations (EFPIA), the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), the European Association for Bioindustries (EuropaBio) and Vaccines Europe stated their shared and serious concerns over the workability of the… read more

EUCOPE welcomes the European Commission’s Communication on boosting biotechnology and biomanufacturing in the EU

On 20 March, the European Commission’s published the Communication on Building the future with nature: Boosting biotechnology and biomanufacturing in the EU, proposing a series of targeted actions to boost biotechnology and biomanufacturing in the EU. While focussing on the entire biotech sector, the Communication… read more

European Parliament’s ENVI committee adopts reports on the EU Pharmaceutical Package

on ENVI reports on the EU Pharmaceutical Package Today, 19 March 2024, the European Parliament’s Committee on the Environment, Public Health and Food Safety (ENVI) adopted the two reports on the so-called EU Pharmaceutical Package, namely the Directive on Medicinal products for human use and… read more

Interested in becoming a member?

EUCOPE gives voice to small to medium-sized innovative companies active in the field of pharmaceuticals, biotechnologies, and medical technologies at the European level. Learn more about the benefits of membership with EUCOPE.

Benefits of membership